🇺🇸 FDA

Drug profile · INN

amlexanox

APHTHASOL

approved
US status
approved
Patents linked
5
News articles
0

Quick answer

amlexanox (APHTHASOL) is an FDA-listed pharmaceutical active ingredient. Route of administration: dental. Current US regulatory status: approved.

Key facts

INN amlexanox
Brand APHTHASOL
Route DENTAL
Formulation PASTE

Related patents

Search patents →

  1. US 10590142

    Deuterated amlexanox

    Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10214536

    Amlexanox analogs

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9944652

    Deuterated amlexanox

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9365581

    Deuterated amlexanox

    Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8946424

    Deuterated amlexanox

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is amlexanox?

amlexanox (APHTHASOL) is an FDA-listed pharmaceutical active ingredient. Route of administration: dental. Current US regulatory status: approved.

What is the brand name for amlexanox?

APHTHASOL is a marketed brand name for amlexanox. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of amlexanox?

amlexanox has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.